NCT03542552View on ClinicalTrials.gov

Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa

PHASE3CompletedINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

June 1, 2018

Primary Completion Date

March 30, 2021

Study Completion Date

April 30, 2021

Conditions
Placenta Previa
Interventions
DRUG

Magnesium Sulfate

Patients received intravenous 6 g bolus MgSO4 20% followed by a 2 g/h infusion

DRUG

Nifedipine

received oral nifedipine 10 mg every 20 minutes for three doses, followed by 10 mg orally every 6 hours

Trial Locations (1)

Unknown

Assiut university, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03542552 - Nifedipine Versus Magnesium Sulfate for Prevention of Preterm Labor in Symptomatic Placenta Previa | Biotech Hunter | Biotech Hunter